BACKGROUND: Prozone phenomenon is seen with very high-titer antibodies in an immune serum.
Introduction
T he prozone phenomenon, described as masking of serological reaction in undiluted serum but increased strength of reaction upon its dilution, is characteristically associated with certain hyperimmune anti-Rh and antiglobulin sera. [1] It is due to an excess of antibody molecules in the serum blocks the most antigenic sites in such a way that prevents cross-linking of the red blood cells (RBCs). However, the prozone effect occasionally observed with respect to a high-titer ABO antibodies was thought to be due to a steric hindrance created by the complement molecules fixed on the cell surface following antigen-antibody complex formation. [2] A similar observation was reported involving complement-fixing anti-Jk a that had suppressed the reactivity of certain antibodies of the Rh blood groups. [3] We document a case, in which the prozone effect exerted upon anti-D through complement-fixing anti-Le a . As per the best of our knowledge, this is the first case of its kind where the reactivity of a clinically significant anti-D was markedly suppressed by a low titer clinically less significant complement-binding anti-Lewis antibody.
Materials and Methods
Standard serological methods by saline tube/indirect antiglobulin techniques were used in testing throughout. The ABO and RhD blood grouping and antiglobulin reagents were obtained commercially (Span Diagnostic Ltd). The Rh subtyping antisera used were from Ortho Clinical Diagnostics. The Lewis typing was carried out using antibodies identified locally using appropriate controls being run in parallel to the test. Heat inactivation of complement in serum was carried out at 56°C water bath. Immunoglobulin nature of the antibodies was determined using the dithiothreitol (DTT). [4] 
Results

Case detail
The mother, a 26-year-old multipara (4 th gravida, 3 rd para), with neither having history of blood transfusion nor having hemolytic disease of the newborn (HDNB) to her previous children, delivered her 4 th female child at full-term pregnancy. The child weighed 2.3 kg with hemoglobin values of 15.4 g/dL at birth. The child showed a sign of jaundice after 24 h of birth that had progressed to a serum bilirubin level of 27.5 mg/dL (indirect being 24 mg/dL) within the next 48 h. The child was treated with an exchange blood transfusion using 535 ml of homologous blood compatible with her mother's serum by saline, albumin, and antiglobulin methods. The child was grouped as A, RhD+, CDe/cde (R 1 r); direct antiglobulin test (DAT) was weakly positive. Her serum contained anti-D and anti-Le a , reacting at 37°C by saline, albumin, and antiglobulin methods, was considered as being passively transferred from her mother during intrauterine life. However, eluate from the child's RBCs showed only anti-D reactive by albumin/enzyme/indirect antiglobulin testing (IAT) at 37°C so was considered as the cause of her jaundice. The mother was grouped as A 1 , RhD-negative (cde/cde, rr), Le (a−b−), and the antibody screen test (AST) on her serum was positive due to the presence of the alloantibody (ies) reacting weakly at 37°C by the albumin/enzyme/IAT methods.
Her husband was grouped as A 1 , RhD positive (CDe/ CDe, R 1 R 1 ), Le (a+b−) and reacted with her serum by the methods employed.
Further investigations showed that the serum reacted with the RBCs in variable strength and at different phases indicating toward multiple specificities. Her serum caused complement-mediated hemolysis of the enzyme premodified red cells having Le a antigens indicating to the anti-Le a being one of the specificities. The presence of anti-D was revealed when the serum reacted with all the ten examples of the enzyme premodified RBCs typed as RhD+, Le (a−) but failed to do so with 11 enzyme-treated RhD-, Le (a−) red cells. Anti-D was also clearly shown upon neutralization of anti-Le a by saliva from individual with Le (a+b−) phenotype. To obviate complement-mediated hemolysis that interfered in expression of anti-D, her serum decomplemented by heating at 56°C or the complement activation pathway was blocked by adding sodium citrate solution to serum to arrest the ionized Ca ++ . The results are summarized in Table 1 . 
Discussion
Prozone phenomenon, characterized by a weak or no agglutination of the RBCs in undiluted serum having antibody but agglutinated upon dilution of the serum, has long been recognized and considered to be due to an excess of antibody molecules that block and so deprive the antigen sites for agglutinating antibodies. The prozone effect is usually observed with the hyperimmune anti-D or antiglobulin serum.
[1] lyse enzyme-treated cells. [9] The presence of anti-D was revealed when, [10] Spitalnik et al. [11] detected IgG anti-Le a in 12 of the 13 cord sera tested by kinetic enzyme-linked immunosorbent assay indicating that the IgG anti-Le a antibodies do cross the placenta though they do not cause HDNB because of the low levels of Lewis antigens on fetal red cells. However, the mild HDNB due to anti-Le a [12] and anti-Le b [13, 14] has been documented in literature.
The clinical relevance of the complement-mediated prozone phenomenon needs to be kept in mind while using clinical laboratory evidence in evaluating the HDNB, as anti-Lewis is largely complement binding and often found among the pregnant women. [11, 15] 
Conclusion
In vitro masking on expression of anti-D in serum of the mother, who delivered a child with HDNB, was evidently exerted by the complement-fixing anti-Le a .
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The prozone effect was reported in the hyperimmune ABO blood group antibodies and was thought to be due to the fixation of the C1 complex resulting through the complement activation. [2, 3] As upon activation of the complement pathway through antigen-antibody interaction on the red cell surface, an accumulation of the C1q, C1r, and C1s forms a large macromolecular complex, with a molecular weight of 700,000, and its deposition on the sensitized red cells may cause a nonspecific physical hindrance at the second stage of hemagglutination by maintaining an intracellular distance greater than that can be bridged by the antibodies. [2] Complement-mediated suppression of hemagglutination was also observed on the reactivity of anti-Rh other than anti-D by the complement-fixing anti-Jk a present in the serum. [5] In the present case, the depressed reactivity of anti-D by coexisting complement-binding anti-Le a deserves the merit to be the first of its kind.
Recently, the role of complement activation as the cause of the prozone phenomenon with respect to the human leukocyte antigen antibody has also been reported. [6, 7] This phenomenon of the complement-mediated hindrance on serological reaction was thought not same as the prozone phenomenon because while the prozone effect can be obviated by diluting the serum, it is not prevented by adding ethylenediaminetetraacetic acid [EDTA] to the sample or inactivating the serum by heating at 56°C. [8] A positive DAT on the newborn child and the concurrent presence of a high-titer antibody in the mother point toward the diagnosis of the HDNB. In the present case, these two features were present though, to our surprise, the AST on the mother's serum was not that strong as to produce the HDNB. As a matter of fact, the mother's serum showed a variable reaction pattern with different red cells in the panel indicating to a mixture of antibodies to be present. Serum gave gross hemolysis with the papain enzyme-treated red cells carrying Le a antigen indicating to anti-Le a specificity. The anti-Le a sera that fail to lyse untreated test cells almost always 
